MedTrace Logo

Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder

NCT05310786 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2025-02-25

No results posted yet for this study

Summary

This project will provide novel empirical information about how to optimally engage pharmacists and pharmacies as key partners in collaborative integrated care models designed to expand access to evidence-based medication treatment for OUD which may inform a larger experimental design that seeks to evaluate best ways to scale-up this model across the nation. This Phase 1 project seeks to evaluate the feasibility, acceptability, and impact of implementing a pharmacist-integrated model of MOUD into approximately four diverse outpatient clinical sites.

Conditions

Interventions

OTHER

Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO)

This is not a true intervention, but rather a clinical model of care established at an FQHC in Maine.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Trustees of Dartmouth College

    lead OTHER

Principal Investigators

  • Lisa A Marsch, PhD · Geisel School of Medicine at Dartmouth College

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-18
Primary Completion
2024-08-31
Completion
2025-02-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05310786 on ClinicalTrials.gov